American Eagle’s Partnership with CBD Producer Spurns Complaints from Concerned Parents
The wildly popular cannabinoid is creating lucrative opportunities for investors, but still maintains a dubious status with the Food & Drug Administration.
MORE STORIES LIKE THIS
Hardee’s Lawsuit Targets Franchisee as 77 Restaurants Prepare to Shut Down
RF Investment Partners and Burlington Capital Join Forces to Acquire Top Precision Garage Door Franchise
Possible Pizza Hut Sale Signals Shift in Yum! Brands’ Franchise Strategy
Private Equity Fuels Jiffy Lube’s Next Chapter as Monomoy Strikes $1.3 Billion Deal
/story1/2710565/8d27c1b49f8d229337f891d1710953086382.jpg)

/story1/2731084/bf66466cbd4df59491d91e06fe1696541153.jpg)
/story1/2731656/1773358186_2731656.png)
/story1/2731599/1892c6e35f792878e270881ca55c97975627.jpg)
/story1/2731641/be2969049179e2a832b4cc361f3e9a2c5905.jpg)
/story1/2731616/1febe51044a7db8f2d114b9fda04993b3799.jpg)
/story1/2731700/1773781005_2731700.png)
/story1/2731699/1773769265_2731699.png)
/story1/2731639/1773175532_2731639.png)
/story1/2731668/MinutemanP_1773674086513.png)